Condition: Rheumatoid Arthritis · Ankylosing Spondylitis · Psoriatic Arthritis · Sponsor: Seoul National University Hospital
We established a nationwide biologics and targeted synthetic DMARDs registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients receiving biologics or targeted synthetic DMARDs. As this registry is to observe the "real world" use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is planned.
This description comes directly from the study's public registry record.
Kichul Shin, MD · kideb1@snu.ac.kr
Keunyoung O · yo8313@hanmail.net
Always discuss trial participation with your own doctor first.
| Seoul Metropolitan Government-Seoul National University Boramae Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01965132